# Invesco CurrencyShares Australian Dollar Trust: financial statements, quarterly

FXA · NYSE · CIK 1353614 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fxa.md) · [Financials](/companies/fxa/financials.md) · [Filings](/companies/fxa/filings.md) · [Insiders](/companies/fxa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fxa/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [291](/filings/0000950170-24-122614.md) | [321 d](/filings/0000950170-25-027258.md) | [370](/filings/0000950170-25-067222.md) | [332](/filings/0000950170-25-105204.md) | [344](/filings/0001193125-25-270327.md) | [311 d](/filings/0001193125-26-083544.md) | [288](/filings/0001193125-26-209739.md) | [330](/filings/0001193125-26-338710.md) | [306](/filings/0001193125-25-270327.md) | [260 d](/filings/0001193125-26-083544.md) | [360](/filings/0001193125-26-209739.md) | [491](/filings/0001193125-26-338710.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [0.0 d](/filings/0000950170-23-060472.md) | [0.0 d](/filings/0000950170-24-019069.md) | [0.0](/filings/0000950170-24-054961.md) | [0.0 d](/filings/0000950170-24-092101.md) | [0.0 d](/filings/0000950170-24-122614.md) | [0.0 d](/filings/0000950170-25-027258.md) | [0.0](/filings/0000950170-25-067222.md) | [0.0 d](/filings/0000950170-25-105204.md) | [0.0 d](/filings/0001193125-25-270327.md) | [0.0 d](/filings/0001193125-26-083544.md) | [0.0](/filings/0001193125-26-209739.md) | [0.0 d](/filings/0001193125-26-338710.md) |
| Net income | $k | [222](/filings/0000950170-24-122614.md) | [249 d](/filings/0000950170-25-027258.md) | [294](/filings/0000950170-25-067222.md) | [264](/filings/0000950170-25-105204.md) | [273](/filings/0001193125-25-270327.md) | [247 d](/filings/0001193125-26-083544.md) | [226](/filings/0001193125-26-209739.md) | [249](/filings/0001193125-26-338710.md) | [222](/filings/0001193125-25-270327.md) | [182 d](/filings/0001193125-26-083544.md) | [264](/filings/0001193125-26-209739.md) | [386](/filings/0001193125-26-338710.md) |
| Diluted EPS | $ per share | [0.21](/filings/0000950170-24-122614.md) | not reported | [0.25](/filings/0000950170-25-067222.md) | [0.25](/filings/0000950170-25-105204.md) | [0.26](/filings/0001193125-25-270327.md) | not reported | [0.22](/filings/0001193125-26-209739.md) | [0.20](/filings/0001193125-26-338710.md) | [0.17](/filings/0001193125-25-270327.md) | not reported | [0.19](/filings/0001193125-26-209739.md) | [0.26](/filings/0001193125-26-338710.md) |
| Basic EPS | $ per share | [0.21](/filings/0000950170-24-122614.md) | not reported | [0.25](/filings/0000950170-25-067222.md) | [0.25](/filings/0000950170-25-105204.md) | [0.26](/filings/0001193125-25-270327.md) | not reported | [0.22](/filings/0001193125-26-209739.md) | [0.20](/filings/0001193125-26-338710.md) | [0.17](/filings/0001193125-25-270327.md) | not reported | [0.19](/filings/0001193125-26-209739.md) | [0.26](/filings/0001193125-26-338710.md) |

- Revenue: us-gaap:Revenues
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [67.1](/filings/0000950170-23-060472.md) | [77.7](/filings/0000950170-25-027258.md) | [67.8](/filings/0000950170-24-054961.md) | [69.4](/filings/0000950170-24-092101.md) | [68.7](/filings/0000950170-24-122614.md) | [64.3](/filings/0001193125-26-083544.md) | [61.7](/filings/0000950170-25-067222.md) | [97.3](/filings/0000950170-25-105204.md) | [75.4](/filings/0001193125-25-270327.md) | [85.8](/filings/0001193125-26-338710.md) | [102](/filings/0001193125-26-209739.md) | [99.4](/filings/0001193125-26-338710.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [67.2](/filings/0000950170-23-060472.md) | [77.8](/filings/0000950170-25-027258.md) | [67.9](/filings/0000950170-24-054961.md) | [69.5](/filings/0000950170-24-092101.md) | [68.8](/filings/0000950170-24-122614.md) | [64.5](/filings/0001193125-26-083544.md) | [61.8](/filings/0000950170-25-067222.md) | [97.4](/filings/0000950170-25-105204.md) | [75.5](/filings/0001193125-25-270327.md) | [89.3](/filings/0001193125-26-338710.md) | [102](/filings/0001193125-26-209739.md) | [103](/filings/0001193125-26-338710.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [0.0](/filings/0000950170-23-060472.md) | [0.0](/filings/0000950170-25-027258.md) | [0.0](/filings/0000950170-24-054961.md) | [0.0](/filings/0000950170-24-092101.md) | [0.0](/filings/0000950170-24-122614.md) | [0.0](/filings/0001193125-26-083544.md) | [0.0](/filings/0000950170-25-067222.md) | [0.0](/filings/0000950170-25-105204.md) | [0.0](/filings/0001193125-25-270327.md) | [3.4](/filings/0001193125-26-338710.md) | [0.0](/filings/0001193125-26-209739.md) | [3.5](/filings/0001193125-26-338710.md) |
| Shareholders' equity | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:Cash
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: not reported

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [219 d](/filings/0000950170-24-122614.md) | [219 d](/filings/0000950170-25-027258.md) | [304](/filings/0000950170-25-067222.md) | [267 d](/filings/0000950170-25-105204.md) | [274 d](/filings/0001193125-25-270327.md) | [257 d](/filings/0001193125-26-083544.md) | [231](/filings/0001193125-26-209739.md) | [231 d](/filings/0001193125-26-338710.md) | [253 d](/filings/0001193125-25-270327.md) | [178 d](/filings/0001193125-26-083544.md) | [223](/filings/0001193125-26-209739.md) | [360 d](/filings/0001193125-26-338710.md) |
| Dividends paid | $k | [217](/filings/0000950170-24-122614.md) | [228 d](/filings/0000950170-25-027258.md) | [305](/filings/0000950170-25-067222.md) | [265](/filings/0000950170-25-105204.md) | [274](/filings/0001193125-25-270327.md) | [250 d](/filings/0001193125-26-083544.md) | [235](/filings/0001193125-26-209739.md) | [254](/filings/0001193125-26-338710.md) | [239](/filings/0001193125-25-270327.md) | [177 d](/filings/0001193125-26-083544.md) | [235](/filings/0001193125-26-209739.md) | [363](/filings/0001193125-26-338710.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [1,360](/filings/0000950170-23-060472.md) | [1,162](/filings/0000950170-24-054961.md) | [1,086](/filings/0000950170-24-092101.md) | [1,052](/filings/0000950170-24-122614.md) | [1,163](/filings/0000950170-25-067222.md) | [1,050](/filings/0000950170-25-105204.md) | [1,049](/filings/0001193125-25-270327.md) | [1,012](/filings/0001193125-26-209739.md) | [1,278](/filings/0001193125-26-338710.md) | [1,292](/filings/0001193125-25-270327.md) | [1,415](/filings/0001193125-26-209739.md) | [1,499](/filings/0001193125-26-338710.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,450,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338710.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.